Survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis have an increased risk of cardiovascular mortality in the year after diagnosis.
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...
New "energy boosting" tablets have landed nine people in hospital after horrific blisters and sores erupted across their bodies. Students who use the drugs to stay awake so they can study for ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
Purpose: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) associated with the use of nonsteroidal antiinflammatory drugs (NSAIDs) are described. Summary: A search of the English ...
Stock photos of toxic epidermal necrolysis adverse reaction. (Photos: National Skin Centre) The other three people suffered toxic epidermal necrolysis, a more severe form of SJS. "They had serious ...
Checkpoint Therapeutics, Inc. ("Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, ...
The other three suffered toxic epidermal necrolysis, a more severe form of SJS. The HSA said: 'They had serious skin reactions and developed painful blistering rashes and peeling of skin that ...
The other three individuals suffered a more severe form of SJS, toxic epidermal necrolysis (TEN). These people developed serious skin reactions and painful blistering rashes and peeling of skin ...
Bullous and exfoliative dermatitis, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug rash with eosinophilia and systemic symptoms (DRESS), have occurred with PD ...
AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
AstraZeneca's IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results